249 related articles for article (PubMed ID: 32280688)
1. Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis.
Jiang Y; Hu Z; Zuo Z; Li Y; Pu F; Wang B; Tang Y; Guo Y; Tao H
Biomed Res Int; 2020; 2020():4947381. PubMed ID: 32280688
[TBL] [Abstract][Full Text] [Related]
2. Circulating micrornas as potential diagnostic biomarkers for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
Li Y; Zhu L; Zhu C; Chen Y; Yu H; Zhu H; Yin P; Liu M; Li Y; Li H; Gong Z; Hanzi Xu ; Han J
Discov Oncol; 2024 May; 15(1):189. PubMed ID: 38801504
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
[TBL] [Abstract][Full Text] [Related]
4. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
5. The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.
Zhang WT; Zhang GX; Gao SS
Technol Cancer Res Treat; 2021; 20():15330338211011958. PubMed ID: 33902358
[TBL] [Abstract][Full Text] [Related]
6. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data.
Zhang WT; Wang YJ; Zhang GX; Zhang YH; Gao SS
Rev Esp Enferm Dig; 2023 Sep; 115(9):504-514. PubMed ID: 35040334
[TBL] [Abstract][Full Text] [Related]
8. Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis.
Aalami AH; Aalami F; Sahebkar A
Curr Med Chem; 2023; 30(33):3798-3814. PubMed ID: 36411580
[TBL] [Abstract][Full Text] [Related]
9. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X
BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
Xu SL; Tian YY; Zhou Y; Liu LQ
Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
Gao J; Fan YZ; Gao SS; Zhang WT
Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
[TBL] [Abstract][Full Text] [Related]
13. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
Zhang WT; Zhang GX; Zhao RZ; Gao SS
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis.
Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A
Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
19. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis.
He J; Jiang Y; Liu L; Zuo Z; Zeng C
Front Neurol; 2020; 11():610163. PubMed ID: 33597912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
